NDC 60763-482 - GLYCOPYRROLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60763-482
- Package NDCs from labels
- 60763-482-02
- Manufacturer
- Stason Pharmaceuticals | Stason Pharmaceuticals, Inc. | Contract Pharmacal Corp.
- Effective date
- 2021-12-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only | Stason Pharmaceuticals | Stason Pharmaceuticals, Inc. | Contract Pharmacal Corp. | 2021-12-13 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60763-482-02 | 2025-02-17 | C162847 | 48780-1 | f386c64a-19ba-0266-e053-dadaa90a7c1a | GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only |
| 60763-482-02 | 2023-01-30 | C162847 | 48780-1 | f386c64a-19ba-0266-e053-dadaa90a7c1a | GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| 2776665c-c4d9-34f5-e063-6394a90ae4bf | c4454434-1c7d-333d-e053-2a95a90ab641 | 2025-02-17 | Warnings, Adverse reactions | c4454434-1c7d-333d-e053-2a95a90ab641 | ||
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9a3a142c-daaf-79af-e053-2995a90a1c51 | 2025-01-08 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9bde90dd-0300-f705-e053-2a95a90a7ea6 | 2025-01-08 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | d93a9b2b-708d-4db5-8aae-45fd3a7ca65c | 2025-01-06 | Warnings, Adverse reactions | V92SO9WP2I |
| Cuvposa | GLYCOPYRROLATE | Merz Pharmaceuticals, LLC | d200bd44-9856-4104-a29e-a4cca3db6737 | 2024-12-19 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 5ee5f433-fd99-4c8d-8263-b8956d489620 | 2024-12-12 | Warnings, Adverse reactions | V92SO9WP2I |
| glycopyrrolate | GLYCOPYRROLATE | Saptalis Pharmaceuticals, LLC. | 3e6f8091-d6fe-4c8f-b897-606a70bf74bc | 2024-11-12 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | ccafb5c2-86dd-4bb2-883a-c13e3171227c | 2024-10-14 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 987ba524-361e-49c3-9e00-550a78748542 | 2024-10-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 48a8356e-377e-45ef-a1bf-e9ffec051749 | 2024-10-08 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | fcb295e4-038f-4d4f-8786-4fbcd1d3c298 | 2024-10-04 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 33bbc475-2fe3-48ab-8a9d-56d13053593e | 2024-10-04 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Somerset Therapeutics, LLC | 48cfbd5a-b133-4720-9bd7-65296064ea3c | 2024-08-31 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | bfccdb26-5047-4b54-9732-ffac2d78e4d1 | 2024-05-29 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 685aaf64-1a64-42f9-a96f-4764d650c26f | 2024-05-14 | Warnings, Adverse reactions | V92SO9WP2I |
| PREVDUO | NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE | Endo USA | dd8ad38f-247b-4948-a13c-8f3a4921b4f1 | 2024-04-10 | Warnings, Adverse reactions | V92SO9WP2I |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9be0ad4e-3efa-1a24-e053-2995a90a60d5 | 2024-02-22 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.